Virax Biolabs Group Limited
USD3.19
-0.07 (-2.15%)
CEO
James Foster
IPO Date
2022-07-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$3.20
Prev. Close
$3.26
Day Low
$3.16
Day High
$3.54
52W Low
$2.50
52W High
$28.50
Market Cap
$0.00B
Volume
0.03M
| -0.2 |
| 31 Mar 2023 | FY | -15.9% | -63748.3% | -59.8% | -55.6% | 0.02 | 10.61 | -1.4 |
| 31 Mar 2022 | FY | 0.0% | 0.0% | 175.3% | -3508.5% | -0.00 | 0.04 | -121.1 |
| 31 Mar 2021 | FY | -7.6% | -525.8% | 109.2% | -691.7% | -0.30 | 0.05 | -318.0 |
| 31 Mar 2020 | FY | 45.8% | -802.1% | 75.9% | -3543.4% | -0.72 | 0.02 | -258.4 |
| -0.4 |
| 30 Sept 2024 | Q2 | -130.7% | -55651.7% | -31.9% | -29.2% | 0.07 | 11.58 | -0.5 |
| 31 Mar 2024 | Q4 | 50.1% | -4784.7% | -71.3% | -69.7% | 0.04 | 25.94 | -0.1 |
| 30 Sept 2023 | Q2 | 13.7% | -3803.5% | -45.9% | -41.4% | 0.03 | 7.59 | -0.5 |
| 31 Mar 2023 | Q4 | -52.9% | -143301.8% | -44.0% | -40.9% | 0.02 | 10.61 | -0.7 |
| 30 Sept 2022 | Q2 | 2.0% | -25062.7% | -32.9% | -27.2% | 0.00 | 4.64 | -6.4 |
| 31 Mar 2022 | Q4 | 207.6% | 1245.3% | 118.7% | -2374.3% | -0.00 | 0.04 | -44.8 |
| 30 Sept 2021 | Q2 | 0.0% | 0.0% | 74.2% | -566.4% | -0.24 | 0.04 | -93.7 |
| 31 Mar 2021 | Q4 | -21.3% | -280.0% | 51.6% | -326.7% | -0.30 | 0.05 | -168.3 |